Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) EPS (Weighted Average and Diluted): 2011-2024

Historic EPS (Weighted Average and Diluted) for MediWound (MDWD) over the last 9 years, with Dec 2024 value amounting to -$3.03.

  • MediWound's EPS (Weighted Average and Diluted) fell 5243.22% to -$0.59 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.25, marking a year-over-year increase of 99.97%. This contributed to the annual value of -$3.03 for FY2024, which is 304.00% down from last year.
  • As of FY2024, MediWound's EPS (Weighted Average and Diluted) stood at -$3.03, which was down 304.00% from -$0.75 recorded in FY2023.
  • MediWound's 5-year EPS (Weighted Average and Diluted) high stood at -$0.75 for FY2023, and its period low was -$3.93 during FY2022.
  • Over the past 3 years, MediWound's median EPS (Weighted Average and Diluted) value was -$3.03 (recorded in 2024), while the average stood at -$2.57.
  • As far as peak fluctuations go, MediWound's EPS (Weighted Average and Diluted) skyrocketed by 80.92% in 2023, and later crashed by 304.00% in 2024.
  • MediWound's EPS (Weighted Average and Diluted) (Yearly) stood at -$3.48 in 2021, then fell by 12.93% to -$3.93 in 2022, then surged by 80.92% to -$0.75 in 2023, then tumbled by 304.00% to -$3.03 in 2024.